Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.47 |
| ▸ | RELA | Q04206 | 4/20 | 0.46 |
| ▸ | CASP2 | P42575 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.42 |
| ▸ | RRM1 | P23921 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.41 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3394523 | 1.00 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL8723696 | 0.91 | SLC6A5 (0.55) | SLC6A5CASP2NAAAPAOXGNAI3 | |
| SCHEMBL27971595 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27817058 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28264890 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27490298 | 0.88 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL9290507 | 0.87 | NAAA (0.50) | CASP2NAAAPAOXDNM1EPHX1 | |
| SCHEMBL19040774 | 0.87 | CASP2 (0.58) | CASP2NAAADNM1EPHX1 | |
| SCHEMBL28817375 | 0.86 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28093185 | 0.86 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998001570-A2 | MUTATED ANTIBODY-DEPENDENT INFECTION ENHANCING DOMAINS OF HIV | VANDERBILT UNIVERSITY (US) | 1998-01-15 | — | — | WO | claimed |
| EP-2301957-A2 | Altered fibronectin-binding protein of staphylococcus aureus | Wyeth LLC (US) | 2011-03-30 | — | — | EP | disclosed |
| EP-0948625-B1 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS | UNIV TEXAS (US) | 2011-01-26 | — | — | EP | disclosed |
| US-7771731-B2 | Altered fibronectin-binding protein of Staphylococcus aureus | WYETH LLC (US) | 2010-08-10 | — | — | US | disclosed |
| US-7666433-B2 | Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV | WYETH HOLDINGS CORPORATION (US) | 2010-02-23 | — | — | US | disclosed |
| US-7576194-B2 | UspA2 nucleic acid of moraxella catarrhalis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-08-18 | — | — | US | disclosed |
| US-7569683-B2 | UspA2 nucleic acid of Moraxella catarrhalis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-08-04 | — | — | US | disclosed |
| US-20090137788-A1 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-28 | — | — | US | disclosed |
| US-20090118486-A1 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-07 | — | — | US | disclosed |
| US-7344724-B2 | UspA1 and UspA2 antigens of Moraxella catarrhalis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-03-18 | — | — | US | disclosed |
| US-20030175310-A1 | Identification of antigenic peptide sequences | MITCHELL WILLIAM M (US) | 2003-09-18 | — | — | US | disclosed |
| US-20030032772-A1 | UspA1 and UspA2 antigens of moraxella catarrhalis | THE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM | 2003-02-13 | — | — | US | disclosed |
| US-6340463-B1 | FOR THE PRODUCTION OF BOTH POLYCLONAL AND MONOCLONAL ANTIBODIES TO DEFINED ANTIGENIC DOMAINS | VANDERBILT UNIVERSITY | 2002-01-22 | — | — | US | disclosed |
| US-6310190-B1 | NUCLEOTIDE SEQUENCES CODING MICRORGANISM PROTEIN; FOR USE IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF INFECTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS | 2001-10-30 | — | — | US | disclosed |
| EP-1015595-A1 | PEPTIDES DERIVED FROM THE ATTACHMENT (G) PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS | AMERICAN CYANAMID COMPANY (US) | 2000-07-05 | — | — | EP | disclosed |
| EP-0948625-A2 | USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1999014334-A1 | PEPTIDES DERIVED FROM THE ATTACHMENT (G) PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS | AMERICAN CYANAMID COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998028333-A9 | USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) | — | 1998-10-22 | — | — | WO | disclosed |
| WO-1998028333-A2 | USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998001570-A2 | MUTATED ANTIBODY-DEPENDENT INFECTION ENHANCING DOMAINS OF HIV | VANDERBILT UNIVERSITY (US) | 1998-01-15 | — | — | WO | disclosed |